Close

Environmental, Industrial and Agricultural Applications Of Biotechnology Featured At BIO 2000

WASHINGTON, D.C. (March 1, 2000) In addition to health care, biotechnology's impact on the environment, industrial manufacturing and agriculture will be explored at BIO 2000 in Boston, March 26-30...

BIO 2000 Internet News Room Provides Up-To-The-Minute Conference Information

WASHINGTON, D.C. (February 29, 2000) -- The Biotechnology Industry Organization (BIO) has placed on its website (www.bio.org) a BIO 2000 News Room to provide journalists with information related to...

BIO 2000 Examines Advances In Genomics, Gene Therapy

WASHINGTON, D.C. (February 25, 2000) Genomics has captured the attention of Wall Street investors and the imagination of others worldwide as researchers near completion of their work to determine...

BIO Opposes Mandatory Labeling Bill Introduced by Sen. Boxer

WASHINGTON, D.C. (February 23, 2000) The BiotechnologyIndustry Organization (BIO) issued the following statement in response to the bill introduced by U.S. Sen. Barbara Boxer (D-Calif.) Tuesday...

BIO's Comments Regarding Proposed Standards For The Privacy of Individually Identifiable Health Information

EXECUTIVE SUMMARY

BIO represents over 850 biotechnology companies, academic institutions, state biotechnology centers, and related organizations in 46 states and more than 25...

Comments on Proposed Standards for Privacy of Individually Identifiable Health Information

Addressed to Margaret Ann Hamburg, M.D., Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services.

Christopher Reeve Among Speakers at BIO 2000

WASHINGTON, D.C. (February 14, 2000) - Christopher Reeve, paralyzed five years ago after a fall during an equestrian competition, will discuss his life and work at BIO 2000 in Boston.

Reeve,...

Price Controls Will Hurt Patients, Biotech Innovation

WASHINGTON, D.C. (February 11, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a proposal by New England legislators...

BIO Fully Supports President's Ban On Genetic Discrimination

WASHINGTON, D.C. (February 8, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today on President Clinton's executive order...

Testimony of H. Stewart Parker

On behalf of the Biotechnology Industry Organization (BIO), on oversight of gene therapy before the U.S. Senate Health, Education, Labor and Pensions Subcommittee on Public Health.